Multidrug resistance-associated transporter 2 regulates mucosal inflammation by facilitating the synthesis of hepoxilin A3

Journal of Immunology

Volumn 181, Issue 11, 2009, Pages 8044-8052

  Pazos, Michael ^a   Siccardi, Dario ^a,b   Mumy, Karen L ^a,b   Bien, Jeffrey D ^a   Louie, Steve ^a   Shi, Hai Ning ^a   Gronert, Karsten ^c   Mrsny, Randall J ^d,e   McCormick, Beth A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of Bath   (United Kingdom)

^e Unity Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPOXILIN A; MULTIDRUG RESISTANCE PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENTERITIS; FATTY ACID SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

EID: 71849096364     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.11.8044     Document Type: Article

References (49)

1. McCormick, B. A., P. M. Hofman, J. Kim, D. K. Carnes, S. I. Miller, and J. L. Madara. 1995. Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J. Cell Biol. 131: 1599-1608.
2. 3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia. Proc. Natl. Acad. Sci. USA 101: 7421-7426.
3. Pace-Asciak, C. R., D. Reynaud, P. Demin, and S. Nigam. 1999. The hepoxilins: a review. Adv. Exp. Med. Biol. 447: 123-132.
4. Nigam, S., M. P. Zafiriou, R. Deva, R. Ciccoli, and R. Roux-Van der Merwe. 2007. Structure, biochemistry and biology of hepoxilins: an update. FEBS J. 274: 3503-3512. (Pubitemid 47052415)
5. 3 synthase activity. J. Biol. Chem. 279: 29023-29030.
6. Yu, Z., C. Schneider, W. E. Boeglin, L. J. Marnett, and A. R. Brash. 2003. The lipoxygenase gene ALOXE3 implicated in skin differentiation encodes a hydroperoxide isomerase. Proc. Natl. Acad. Sci. USA 100: 9162-9167. (Pubitemid 37033900)
7. 3. J. Immunol. 173: 5712-5720.
8. 3-mediated neutrophil transepithelial migration. Clin. Exp. Immunol. 151: 297-305.
9. 2 mediate the ability of Salmonella enterica serotype Typhimurium and Shigella flexneri to induce the transepithelial migration of neutrophils. Infect. Immun. 76: 3614-3627.
10. McCormick, B. A., C. A. Parkos, S. P. Colgan, D. K. Carnes, and J. L. Madara. 1998. Apical secretion of a pathogen-elicited epithelial chemoattractant activity in response to surface colonization of intestinal epithelia by Salmonella typhimurium. J. Immunol. 160: 455-466.
11. Wakabayashi, K., A. Tamura, H. Saito, Y. Onishi, and T. Ishikawa. 2006. Human ABC transporter ABCG2 in xenobiotic protection and redox biology. Drug Metab. Rev. 38: 371-391. (Pubitemid 44167196)
12. McCormick, B. A., S. P. Colgan, C. Delp-Archer, S. I. Miller, and J. L. Madara. 1993. Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J. Cell Biol. 123: 895-907. (Pubitemid 23333578)
13. Lee, C. A., M. Silva, A. M. Siber, A. J. Kelly, E. Galyov, and B. A. McCormick. 2000. A secreted Salmonella protein induces a proinflammatory response in epithelial cells, which promotes neutrophil migration. Proc. Natl. Acad. Sci. USA 97: 12283-12288.
14. Gronert, K., C. B. Clish, M. Romano, and C. N. Serhan. 1999. Transcellular regulation of eicosanoid biosynthesis. Methods Mol. Biol. 120: 119-144.
15. Murphy, R. C., R. M. Barkley, K. Zemski Berry, J. Hankin, K. Harrison, C. Johnson, J. Krank, A. McAnoy, C. Uhlson, and S. Zarini. 2005. Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal. Biochem. 346: 1-42. (Pubitemid 41456623)
16. Barthel, M., S. Hapfelmeier, L. Quintanilla-Martinez, M. Kremer, M. Rohde, M. Hogardt, K. Pfeffer, H. Russmann, and W. D. Hardt. 2003. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71: 2839-2858. (Pubitemid 36519898)
17. Chen, C. C., S. Louie, B. McCormick, W. A. Walker, and H. N. Shi. 2005. Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice. Infect. Immun. 73: 5468-5481.
18. Lindenmaier, H., M. Becker, W. E. Haefeli, and J. Weiss. 2005. Interaction of progestins with the human multidrug resistance-associated protein 2 (MRP2). Drug Metab. Dispos. 33: 1576-1579. (Pubitemid 41539950)
19. Siccardi, D., L. E. Kandalaft, M. Gumbleton, and C. McGuigan. 2003. Stereoselective and concentration-dependent polarized epithelial permeability of a series of phosphoramidate triester prodrugs of d4T: an in vitro study in Caco-2 and Madin-Darby canine kidney cell monolayers. J. Pharmacol. Exp. Ther. 307: 1112-1119. (Pubitemid 37494231)
20. Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553. (Pubitemid 34408678)
21. Siccardi, D., K. L. Mumy, D. M. Wall, J. D. Bien, and B. A. McCormick. 2008. Salmonella enterica serovar Typhimurium modulates P-glycoprotein in the intestinal epithelium. Am. J. Physiol. 294: G1392-G1400.
22. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5: 1461-1471.
23. + T cells. J. Exp. Med. 178: 237-244.
24. Totsuka, T., T. Kanai, K. Uraushihara, R. Iiyama, M. Yamazaki, H. Akiba, H. Yagita, K. Okumura, and M. Watanabe. 2003. Therapeutic effect of anti-OX40L and anti-TNF-α MAbs in a murine model of chronic colitis. Am. J. Physiol. 284: G595-G603. (Pubitemid 36343209)
25. Chan, L. M., S. Lowes, and B. H. Hirst. 2004. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm .Sci. 21: 25-51.
26. Kullak-Ublick, G. A., and M. B. Becker. 2003. Regulation of drug and bile salt transporters in liver and intestine. Drug Metab. Rev. 35: 305-317. (Pubitemid 38018109)
27. Prime-Chapman, H. M., R. A. Fearn, A. E. Cooper, V. Moore, and B. H. Hirst. 2004. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells. J. Pharmacol. Exp. Ther. 311: 476-484.
28. Kruijtzer, C. M., J. H. Beijnen, and J. H. Schellens. 2002. Improvement of oral drug treatment by temporary inhibition of drug transporters and/or cytochrome P450 in the gastrointestinal tract and liver: an overview. Oncologist 7: 516-530.
29. Shen, H., S. Paul, L. M. Breuninger, P. J. Ciaccio, N. M. Laing, M. Helt, K. D. Tew, and G. D. Kruh. 1996. Cellular and in vitro transport of glutathione conjugates by MRP. Biochemistry 35: 5719-5725. (Pubitemid 26143667)
30. Leier, I., G. Jedlitschky, U. Buchholz, M. Center, S. P. Cole, R. G. Deeley, and D. Keppler. 1996. ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem. J. 314: 433-437. (Pubitemid 26075650)
31. Muller, M., C. Meijer, G. J. Zaman, P. Borst, R. J. Scheper, N. H. Mulder, E. G. de Vries, and P. L. Jansen. 1994. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA 91: 13033-13037.
32. 4 and chemotherapeutic agents in membrane vesicles: demonstration of glutathione-dependent vincristine transport. J. Biol. Chem. 271: 9675-9682.
33. Zhang, S., R. L. Santos, R. M. Tsolis, S. Stender, W. D. Hardt, A. J. Baumler, and L. G. Adams. 2002. The Salmonella enterica serotype typhimurium effector proteins SipA, SopA, SopB, SopD, and SopE2 act in concert to induce diarrhea in calves. Infect. Immun. 70: 3843-3855. (Pubitemid 34666025)
34. Shannon, V. R., W. F. Stenson, and M. J. Holtzman. 1993. Induction of epithelial arachidonate 12-lipoxygenase at active sites of inflammatory bowel disease. Am. J. Physiol. 264: G104-G111.
35. Yamamoto, S., K. Kishimoto, T. Arakawa, H. Suzuki, M. Nakamura, T. Yoshimoto, T. Takao, Y. Shimonishi, and T. Tanabe. 1997. Arachidonate 12-lipoxygenases: catalytic properties and regulation of the enzyme gene. Adv. Exp. Med. Biol. 407: 191-196. (Pubitemid 27440727)
36. Yoshimoto, T., and S. Yamamoto. 1995. Arachidonate 12-lipoxygenase. J. Lipid Mediat. Cell Signal 12: 195-212.
37. Yamamoto, S., H. Suzuki, M. Nakamura, and K. Ishimura. 1999. Arachidonate 12-lipoxygenase isozymes. Adv. Exp. Med. Biol. 447: 37-44.
38. Funk, C. D., X. S. Chen, E. N. Johnson, and L. Zhao. 2002. Lipoxygenase genes and their targeted disruption. Prostaglandins Other Lipid Mediat. 68-69: 303-312.
39. Collins, J. F., Z. Hu, P. N. Ranganathan, D. Feng, L. M. Garrick, M. D. Garrick, and R. W. Browne. 2008. Induction of arachidonate 12-lipoxygenase (Alox15) in intestine of iron-deficient rats correlates with the production of biologically active lipid mediators. Am. J. Physiol. 294: G948-G962.
40. Pace-Asciak, C. R., and S. Asotra. 1989. Biosynthesis, catabolism, and biological properties of HPETEs, hydroperoxide derivatives of arachidonic acid. Free Radical Biol. Med. 7: 409-433.
41. Mackay, F., J. L. Browning, P. Lawton, S. A. Shah, M. Comiskey, A. K. Bhan, E. Mizoguchi, C. Terhorst, and S. J. Simpson. 1998. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology 115: 1464-1475. (Pubitemid 28545997)
42. Philippe, D., L. Dubuquoy, H. Groux, V. Brun, M. T. Chuoi-Mariot, C. Gaveriaux-Ruff, J. F. Colombel, B. L. Kieffer, and P. Desreumaux. 2003. Anti-inflammatory properties of the μ opioid receptor support its use in the treatment of colon inflammation. J. Clin. Invest. 111: 1329-1338. (Pubitemid 36554703)
43. McCormick, B. A., S. I. Miller, D. Carnes, and J. L. Madara. 1995. Transepithelial signaling to neutrophils by salmonellae: a novel virulence mechanism for gastroenteritis. Infect. Immun. 63: 2302-2309.
44. Van Aubel, R. A., A. Hartog, R. J. Bindels, C. H. Van Os, and F. G. Russel. 2000. Expression and immunolocalization of multidrug resistance protein 2 in rabbit small intestine. Eur. J. Pharmacol. 400: 195-198. (Pubitemid 30438726)
45. Kuhn, H., M. Walther, and R. J. Kuban. 2002. Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications. Prostaglandins Other Lipid Mediat. 68-69: 263-290. (Pubitemid 35247401)
46. Kuhn, H., and V. B. O'Donnell. 2006. Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 45: 334-356.
47. Sorokin, A. 2004. Cyclooxygenase-2: potential role in regulation of drug efflux and multidrug resistance phenotype. Curr. Pharm. Des. 10: 647-657. (Pubitemid 38292391)
48. Panwala, C. M., J. C. Jones, and J. L. Viney. 1998. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J. Immunol. 161: 5733-5744.
49. Laouari, D., R. Yang, C. Veau, I. Blanke, and G. Friedlander. 2001. Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure. Am. J. Physiol. 280: F636-F645. (Pubitemid 32473261)